STEJI KOSHY: Open Payments
NPI 1982087946 · APACHE JUNCTION, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,721 in 50 payments from 12 companies in 2025. Trend: 2023 $882 · 2024 $1,275 · 2025 $1,721
Food & beverage: $1,721
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 6 | $277 |
| Otsuka America Pharmaceutical, Inc. | 9 | $267 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $262 |
| Neurocrine BioSciences, Inc. | 5 | $214 |
| Alkermes, Inc. | 5 | $206 |
| Axsome Therapeutics, Inc. | 3 | $169 |
| Teva Pharmaceuticals USA, Inc. | 5 | $120 |
| ABBVIE INC. | 5 | $103 |
| Braeburn Inc. | 2 | $43 |
| Corium, LLC | 1 | $26 |
Products named: COBENFY, CAPLYTA, INGREZZA, ABILIFY MAINTENA, Auvelity, LYBALVI, VRAYLAR, UZEDY.
Industry payments across AZ — which companies pay providers there.
